@ the Leukemia Atlases


Acute leukemias are extremely heterogeneous cancers of the blood and bone marrow. No known single attributes account for the diversity in response of adult and pediatric leukemia patients to chemotherapy. To address this clinical challenge and shed insight in the underlying biology of leukemia, we developed the Leukemia Proteome Atlases.


The atlases display in an interactive format, results from applying MetaGalaxy, a novel computational pipeline we designed, to proteomic data from leukemia patients' bone marrow biopsies. Patient outcomes were followed for 6 months to >>6 years. MetaGalaxy identifies functional protein networks and a global network signature that are indicative of clinical outcomes for patients with acute leukemias.


The atlases are divided into Adult and Pediatric, and the type of diagnosed leukemia (acute myeloid or acute lymphoblastic leukemia). Both global networks, the result of analyzing all protein functional groups simultaneous for all patients, and signatures from the individual protein functional groups are provided. 

Overall, the Leukemia Proteome Atlases provide quantitative, molecular hallmarks of leukemia; a broadly applicable computational approach to quantifying heterogeneity and similarity in molecular data; and a guide to new therapeutic targets for leukemias. 



Steven M. Kornblau, MD

Amina Ann Qutub, PhD

Terzah Horton, MD, PhD

Eveline de Bont, MD, PhD


Chenyue Wendy Hu, PhD

Yihu Qiu, PhD

Fieke Hoff

Andrew Ligeralde

Suk Young Yoo, PhD

Kevin Coombes, PhD

Alexandria Raybon

Anneke van Dijk

André Schultz, PhD

David Noren, PhD

Alex J. Bisberg

Quentin Li

Byron Long, PhD

Jennifer Dawkins